Incidence and risk factors of immune reconstitution inflammatory syndrome in HIV-TB coinfected patients

• Published in: The Brazilian journal of infectious diseases Vol. 15; no. 6; pp. 553 - 559
• Main Authors: De, Dibyendu, Nath Sarkar, Rathindra, Phaujdar, Sibaji, Bhattacharyya, Kuntal, Krishna Pal, Hare
• Format: Journal Article
• Language: English
• Published: Brazil Elsevier Editora Ltda 01.11.2011; Contexto; Elsevier
• Subjects: Adult; AIDS-Related Opportunistic Infections - drug therapy; AIDS-Related Opportunistic Infections - epidemiology; Anti-Retroviral Agents - adverse effects; Anti-Retroviral Agents - therapeutic use; Antitubercular agents; Antitubercular Agents - adverse effects; Antitubercular Agents - therapeutic use; Antiviral agents; CD4 Lymphocyte Count; Comorbidity; Cross-Sectional Studies; Female; Highly active antiretroviral therapy; HIV; HIV (Viruses); HIV patients; Humans; Immune reconstitution inflammatory syndrome; Immune Reconstitution Inflammatory Syndrome - chemically induced; Immune Reconstitution Inflammatory Syndrome - diagnosis; Immune Reconstitution Inflammatory Syndrome - epidemiology; Incidence; India - epidemiology; Male; Middle Aged; Risk Factors; Tuberculosis; Tuberculosis, Pulmonary - drug therapy; Tuberculosis, Pulmonary - epidemiology; India; Immune reconstitution inflammatory syndrome; Tuberculosis; HIV; CD4 lymphocyte count

Tuberculosis is one of the leading causes of development of Immune reconstitution inflammatory syndrome (IRIS) in HIV patients receiving antiretroviral therapy (ART). To determine the incidence of IRIS in HIV-TB coinfected patients, and to find out the possible risk factors associated with IRIS. Stu...